Companies, especially SMEs, can face significant challenges trying to introduce their new and innovative products into the NHS. The complexity of public procurement, understanding what information the NHS requires for a business case and negotiating what is often a ‘risk-averse’ culture across multiple organisations can be daunting.
GM AHSN has first-hand experience and expert knowledge of the NHS to offer advice and support to SMEs.
It has recently launched the Innovation Nexus at www.intohealth.org which aims to provide a single resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and more widely with fewer unanticipated obstacles.
The Innovation Nexus provides information, access and support – everything businesses need to develop, test and deliver innovative products and services in collaboration with the NHS.
Organisations can arrange an initial consultation with one of the GM AHSN’s expert advisors by visiting www.intohealth.org. These advisors bring together expertise across all aspects of working with the NHS, from trials, evaluation and market needs analysis to procurement and adoption.